MTT Assay: Mechanism, Protocol, and Alternatives

MTT is a yellow dye that living cells convert into purple crystals, and measuring the intensity of that purple color tells researchers how many viable cells are in a sample. Formally named 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, the MTT assay has been a workhorse of biomedical labs since the early 1980s, used in everything from cancer drug screening to testing whether a new dental implant material is safe for human tissue. Its appeal is straightforward: it is fast, cheap, and fits neatly into the 96-well plates that let scientists run dozens of experiments at once. But its simplicity masks real limitations that can skew results badly if you don’t know where to look.

How the Assay Was Born

The MTT assay was introduced in 1983 by Tim Mosmann, who was looking for a way to measure immune cell growth without using radioactive materials. The standard method at the time involved feeding cells a radioactive form of thymidine and then measuring how much they incorporated into their DNA. It worked, but handling radioactive waste was expensive, slow, and hazardous. Mosmann showed that MTT offered a quantitative colorimetric alternative that could be read on the same plate readers already sitting in most labs, with high precision and no washing steps required.¹ The paper became one of the most cited in immunology, and the assay quickly spread beyond immune cells to virtually every field that works with cultured cells.

What Happens Inside the Cell

When you add MTT solution to a plate of living cells, the yellow dye enters the cells and gets chemically reduced by enzymes called NAD-dependent oxidoreductases. These enzymes strip electrons from metabolic molecules and hand them to the MTT molecule, which transforms it into an insoluble purple compound called formazan.² Dead cells can’t perform this conversion because their metabolic machinery has shut down. More living, metabolically active cells means more purple formazan, and therefore a darker solution once you dissolve the crystals.

Where exactly this conversion takes place inside the cell has been a subject of study. Research using fluorescent trackers found that MTT reduction is largely confined to intracellular vesicles, some of which were identified as endosomes and lysosomes. These vesicles eventually push needle-like formazan crystals to the cell surface.³ This detail matters because it means the assay isn’t purely measuring mitochondrial activity, as textbooks sometimes imply. The reduction happens across several compartments, and the balance between them can shift depending on cell type and treatment conditions.

Running the Assay Step by Step

In practice, you seed cells into the wells of a microplate, treat them with whatever compound or condition you’re testing, then add MTT reagent and incubate for a few hours. During that incubation, surviving cells churn out purple formazan crystals. The tricky part comes next: formazan is insoluble in water, so you need a solvent to dissolve the crystals before you can read the plate. DMSO is the most widely used solvent for this step and tends to give the most consistent results, particularly when residual culture medium is still present in the wells.⁴

Getting the dissolution step right is more important than it sounds. Incomplete dissolution of the formazan crystals leads to inaccurate readings, and protein precipitation in diluted solvents can also muddy the results.⁵ For bacterial applications, where the cells and their metabolic products differ from mammalian cultures, special attention to solubilization protocols has been shown to improve accuracy.⁶

Once everything is dissolved, you slide the plate into a spectrophotometer and measure absorbance at around 570 nanometers, the wavelength where formazan absorbs light most strongly. Higher absorbance equals more formazan, which is assumed to equal more living cells.⁷ That assumption is where trouble can begin.

Drug Screening and IC50 Measurements

The most common use of the MTT assay is figuring out how effectively a drug kills cells, often expressed as an IC50, the concentration at which half the cells die. Cancer researchers rely heavily on this number when deciding whether a compound is worth advancing to animal studies. The assay can handle this in both traditional flat-layer cell cultures and in three-dimensional tumor spheroids, which mimic real tumor architecture more closely. In one study using breast cancer cells treated with tamoxifen, the IC50 measured in flat culture was about 8 µM, while the same cells grown as spheroids showed roughly 21 µM, reflecting the added resistance that comes from cells being packed in layers rather than spread out on a dish.⁸

That kind of comparison is useful, but the underlying IC50 values themselves can be unreliable when measured by MTT alone. A study dissecting the technical deficiencies of MTT-based IC50 measurements for cisplatin found errors ranging from 300 to 11,000 percent compared with direct cell counts.⁹ Errors that large are not rounding issues; they can lead a research team to believe a drug is potent when it barely works, or vice versa. The source of these errors ties directly to the biological limitations discussed in the next section.

Biocompatibility Testing for Medical Devices

Outside drug discovery, MTT is a standard tool for evaluating whether a medical device material is toxic to cells. The international standard ISO 10993-5 governs this kind of testing, and labs commonly use MTT, XTT, or the neutral red uptake assay to do it. An interlaboratory comparison found that MTT, XTT, and neutral red were the most frequently chosen methods across 52 participating labs for quantitative cytotoxicity assessment of medical devices.¹⁰ The catch is that the same material tested at different labs using different assays sometimes got different pass/fail results, highlighting how sensitive the outcome is to protocol choices.

The Mitochondrial Bias Problem

The MTT assay assumes a clean relationship between absorbance and cell number, but this relationship breaks down when treatments change how metabolically active each surviving cell is. Radiation exposure is a clear example. When researchers compared MTT readings with direct cell counts after irradiating cells, the actual drop in cell number was significantly larger than what MTT suggested. The surviving cells had ramped up their metabolic activity, producing more formazan per cell and masking the true extent of killing.¹¹

Anti-cancer drugs can trigger the same effect. Work on lung and cervical cancer cell lines showed that drug treatment increased per-cell metabolic activity by roughly 1.2- to 3.3-fold. The mechanism turned out to be a drug-concentration-dependent increase in mitochondrial mass and upregulation of succinate dehydrogenase, one of the key enzymes that reduces MTT to formazan. The result was that the assay showed no significant difference from untreated controls, even though direct cell counts confirmed substantial cell killing.¹² In plain terms, the dying cells’ surviving neighbors were working harder metabolically, generating enough extra purple dye to compensate for the missing cells entirely.

Chemical Interference and False Positives

Beyond biological confounders, some test compounds can chemically reduce MTT themselves, without any cells involved at all. This is a particular headache for researchers working with plant-derived compounds. Several plant extracts and phytoestrogens, including kaempferol, resveratrol, St. John’s wort extract, and black cohosh extract, were shown to instantly convert MTT to blue formazan in a cell-free system. Common antioxidants like vitamin C, vitamin E, and N-acetylcysteine also interfered with the assay.¹³ The practical consequence is that these compounds can make it look like more cells survived a treatment than actually did, or even that the compound stimulated growth.

Some researchers have reported strikingly false-positive viability readings when testing herbal extracts. Cells that were visibly dead under a microscope still produced strong MTT signals because the extract itself was doing the chemical work of reducing the dye.¹⁴ Washing the cells before adding MTT can reduce this artifact, but it doesn’t eliminate it for all compounds.

Nanoparticles present another category of interference. Carbon-based nanoparticles can physically adsorb to the MTT dye itself, along with other common assay indicators like alamar blue, neutral red, and WST-1. This binding can either quench or amplify the signal in unpredictable ways.¹⁵ For the growing field of nanomedicine, where safety testing of engineered particles is critical, this means MTT results for nanoparticle toxicity need to be interpreted with extreme caution and confirmed by independent methods.

Environmental toxicology hits the same wall. When researchers used the MTT assay to test dissolved organic matter from wastewater treatment plant effluent, they found that concentrated samples gave much higher signals than untreated control cells, suggesting the wastewater stimulated cell growth. Microscopy showed no such growth. Follow-up with an ATP-based assay and flow cytometry revealed the expected toxicity, confirming that materials in the effluent were chemically reacting with or boosting MTT reduction.¹⁶

Second-Generation Tetrazolium Dyes

Several newer tetrazolium dyes were developed partly to address the dissolution problem. XTT, WST-1, and MTS all produce water-soluble formazans, which means you can read the plate without a separate solubilization step. They also differ from MTT in an important biological way: they carry a net negative charge and can’t easily cross the cell membrane. Their reduction happens primarily at the cell surface or via electron transport across the plasma membrane, rather than inside cytoplasmic vesicles.¹⁷

This surface-level reduction is convenient but introduces its own limitation, especially for three-dimensional cultures. A comparison of XTT, WST-1, and WST-8 applied to human cartilage cells grown as spheroids found evidence that only cells on the outer rim of the spheroid could convert the membrane-impermeable dyes. WST-8 showed the highest sensitivity among the three and was non-toxic to the cells, allowing repeated measurements over time.¹⁸ For flat-layer cultures, these dyes streamline the workflow nicely. For spheroids and organoids, they can undercount interior cells.

Non-Tetrazolium Alternatives

Researchers who need to sidestep the MTT assay’s pitfalls entirely have two main categories of alternatives: fluorescence-based and luminescence-based.

Alamar Blue, also known as resazurin, is a blue non-fluorescent dye that living cells reduce to resorufin, a pink compound that fluoresces strongly. Unlike MTT, the reaction doesn’t kill the cells, so you can measure the same culture repeatedly over days. One lingering uncertainty is whether the reduction happens inside the cell via enzymes or partly as a chemical reaction in the culture medium, though the fluorescent product has been found in the cytoplasm of living cells.¹⁹ The fluorescence readout also means the assay is less susceptible to interference from colored compounds or turbid samples that would throw off a simple absorbance measurement.

ATP-based luminescent assays take a different approach entirely. Instead of measuring metabolic conversion of a dye, they lyse the cells and quantify how much adenosine triphosphate spills out. Because ATP degrades rapidly in dead cells, the amount detected is proportional to the number of living cells at the moment of lysis. Head-to-head comparisons with MTT show a dramatic difference in sensitivity: an ATP assay detected as few as about 1,500 cells per well with luminescence values a hundred times above background, while the MTT assay couldn’t detect below 25,000 cells.²⁰ That makes ATP assays particularly attractive when cell numbers are low or when you need tight dose-response curves at the lower end.

Other validation approaches include the LDH release assay, which measures a different thing entirely: how much of the enzyme lactate dehydrogenase has leaked out of damaged cells into the culture medium. It provides a direct readout of membrane damage rather than metabolic activity, and results from LDH assays have been shown to align well with trypan blue exclusion, the classic method of staining dead cells and counting them under a microscope.²¹

Why Orthogonal Validation Matters

The recurring theme across all the limitations discussed above is that a single assay measuring a single biological readout can mislead you. When MTT says cells are alive, it specifically means those cells are metabolically reducing a dye. That might not be the same as saying the cells are capable of dividing, or that they haven’t committed to a delayed death program, or that the signal even came from cells at all. Experienced researchers treat MTT results as a first pass and confirm findings with at least one orthogonal method: direct counting, ATP measurement, LDH release, flow cytometry, or imaging. The specific second assay depends on what question you’re actually asking. If you want to know whether cells are proliferating, a direct count or DNA-content assay is more informative than another metabolic dye. If you want to know whether cells are dying by a particular mechanism, staining for markers of that death pathway is more informative than any viability readout.

MTT Beyond Mammalian Cells

Although the assay was developed for mammalian immune cells, it has been adapted for bacteria as well. One application involves measuring the metabolic activity of bacterial biofilms, the slimy communities that bacteria form on surfaces. Biofilms are notoriously hard to characterize because the bacteria are embedded in a matrix that resists standard counting methods. Researchers have used MTT to assess biofilm-forming capacity of bacteria in industrial metalworking fluids, and to evaluate how well biocides kill biofilms in those environments.²²

More recently, the assay has been applied to biofilms growing on nanofibrous scaffold materials made from polymers like polycaprolactone (PCL), polylactic acid (PLA), and polyamide (PA). These scaffolds are of interest in tissue engineering and wound care, and knowing whether bacteria can colonize them and remain metabolically active is a practical safety question. A tailored MTT protocol proved suitable for quantifying biofilm metabolic activity on all three material types.²³ The same dissolution challenges that apply to mammalian cells apply here, often compounded by the biofilm matrix itself trapping formazan crystals, which is why optimized solubilization protocols are especially important for bacterial work.

When MTT Is Still the Right Choice

With all its faults, the MTT assay remains entrenched in biomedical research for practical reasons. It requires no specialized equipment beyond a standard plate reader. The reagents cost a fraction of what luminescent kits run. It accommodates enormous throughput when screening chemical libraries against cells. And for routine quality-control applications where the test compounds are well characterized and unlikely to interfere chemically, it performs reliably enough. The danger is treating it as a universal truth machine rather than what it is: a metabolic proxy that correlates with cell number under favorable conditions and misleads under unfavorable ones. Knowing which conditions you’re working under is the difference between useful data and a publishable artifact.